Contract HHSN272201600633P
Applied Stemcell, Inc. · Department Of Health And Human Services · May 5, 2016
Applied Stemcell, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on May 5, 2016 for $7,000 of work in biological product (except diagnostic) manufacturing. Performance is in Menlo Park, CA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 27, 2017.
Contract details
- PIID
- HHSN272201600633P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical- Laboratory Testing
- Place of performance
- Menlo Park, CA
- First action
- May 5, 2016
- Latest action
- July 27, 2017
Description
IGF::OT::IGFPOINT MUTATION SERVICES
Modification timeline
-
July 27, 2017Mod 1$-14.9K
-
May 5, 2016Base award$22.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN272201600633P?
Contract HHSN272201600633P is a federal contract awarded to Applied Stemcell, Inc. by Department Of Health And Human Services on May 5, 2016 for $7,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN272201600633P?
Applied Stemcell, Inc. won contract HHSN272201600633P from Department Of Health And Human Services.
How much is contract HHSN272201600633P worth?
Contract HHSN272201600633P has obligated $7,000 to date.